Showing results (151-160 of 3,179) with videos related to

Sort By:
Pageof 318
Molecular Cancer Research : MCR|September 23, 2022
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian CancerAlexandra McMellen, Tomomi M Yamamoto, Lubna Qamar, et al.
Molecular Cancer Research : MCR|January 7, 2022
Small-Molecule NSC59984 Induces Mutant p53 Degradation through a ROS-ERK2-MDM2 Axis in Cancer CellsShengliang Zhang, Lanlan Zhou, Wafik S El-Deiry
Molecular Cancer Research : MCR|May 31, 2011
SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cellsJacqueline C Shultz, Rachel W Goehe, Charuta S Murudkar, et al.
Molecular Cancer Research : MCR|May 31, 2011
HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cellsXiaohua Li, Alexander Kaplun, Fulvio Lonardo, et al.
Molecular Cancer Research : MCR|July 22, 2011
Hedgehog signaling: networking to nurture a promalignant tumor microenvironmentLillianne G Harris, Rajeev S Samant, Lalita A Shevde
Molecular Cancer Research : MCR|June 15, 2011
The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cellsToshihiko Nishisho, Kenji Hata, Masako Nakanishi, et al.
Molecular Cancer Research : MCR|June 23, 2011
MicroRNA-138 modulates DNA damage response by repressing histone H2AX expressionYemin Wang, Jen-Wei Huang, Ming Li, et al.
Molecular Cancer Research : MCR|July 2, 2011
Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factorsShahreen Amin, Ashok Kumar, Ladan Nilchi, et al.
Molecular Cancer Research : MCR|July 9, 2011
Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cellsBiola M Javierre, Javier Rodriguez-Ubreva, Fatima Al-Shahrour, et al.
Molecular Cancer Research : MCR|June 14, 2011
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markersAndrew J Armstrong, Matthew S Marengo, Sebastian Oltean, et al.
Pageof 318